Comparison of clinical outcomes of multifocal intraocular lenses with +2.50, +3.00 and +3.75 add power, and trifocal intraocular lenses

Session Details

Session Title: Pseudophakic IOLs: Multifocal I

Session Date/Time: Monday 12/09/2016 | 08:00-10:30

Paper Time: 08:24

Venue: Auditorium A

First Author: : O.Muftuoglu TURKEY

Co Author(s): :    R. Aydin                    

Abstract Details

Purpose:

To compare the functional outcoems after implantation of multifocal intraoculat lenses (IOLs) with a +2.50, +3.00 and +3.75 diopter (D) addition power and trifocal intraocular lenses.

Setting:

Medipol University Medical School

Methods:

Patients who underwent multifocal IOL implantation with at least 6-month follow-up were included in the study, 38 eyes of 19 patients had Acrysof Restor +2.50 add, 42 eyes of 21 patients had Acrysof Restor +3.00 D add, 46 eyes of 23 patients had Acriva Reviol +3.75 D add, and 40 eyes of 20 patients had Acriva Trifocal – enhanced depth. Visual acuities for distance, at 32 cm, 40 cm, 50 cm, and 60 cm, contrast sensitivity under photopic, mesopic, and mesopic with glare, spherical and astigmatic defocus, spectacle dependance, patient reported satisfaction, and patient reported visual disturbances were evaluated.

Results:

All IOL groups provided good distance vision. Trifocal group tend to have better intermediate vision than +2.50D, +3.00 D, and +3.75 D group. +3.75 group had best near vision followed by trifocal, +3.00, and +2.50. Hybrid design multifocal IOLs tend to have worse intermediate and near vision at low light levels. There was no significant difference in contrast sensitivity between groups. Although all IOL groups reported minimal visual disturbances, the +2.50 group had the least followed by +3.00 group, trifocal group and +3.75 group

Conclusions:

Trifocal enhanced dept multifocal IOLs have relatively better intermediate vision than multifocal IOLs.

Financial Disclosure:

NONE